+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Female Infertility Diagnosis & Treatment Market - Global Forecast 2025-2030- Product Image
Female Infertility Diagnosis & Treatment Market - Global Forecast 2025-2030- Product Image
Sale

Female Infertility Diagnosis & Treatment Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977741
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Female Infertility Diagnosis & Treatment Market is experiencing a period of accelerated innovation and structural change, driven by evolving patient needs, emergent technologies, and dynamic policy developments. As providers, manufacturers, and investors recalibrate strategy, senior leaders face critical inflection points impacting competitive positioning, operational resilience, and market expansion.

Market Snapshot: Female Infertility Diagnosis & Treatment Market

The Female Infertility Diagnosis & Treatment Market grew from USD 4.90 billion in 2024 to USD 5.29 billion in 2025. It is expected to continue expanding at a CAGR of 8.14% to reach USD 7.85 billion by 2030. This trajectory signals sustained demand for innovative diagnostic technologies, advanced reproductive therapies, and operational strategies that can address both patient and provider pain points in a shifting global environment.

Scope & Segmentation

  • Treatment Methods: Assisted reproductive technology such as gamete intrafallopian transfer, in vitro fertilization, intracytoplasmic sperm injection, and intrauterine insemination; cryopreservation including embryo, oocyte, and sperm cryopreservation; fertility medications (clomiphene citrate, gonadotropins, letrozole); and surgical interventions such as hysteroscopic surgery, laparoscopic surgery, myomectomy, and tubal surgery.
  • Diagnosis Techniques: Blood diagnostics with tests for anti-Mullerian hormone, follicle-stimulating hormone, luteinizing hormone, and prolactin; genetic testing; hysterosalpingography; laparoscopy; and ultrasound imaging.
  • Type of Infertility: Primary infertility and secondary infertility.
  • Distribution Channels: Clinic services (general gynecology and specialized fertility clinics), home care testing, hospital services, and independent laboratories.
  • Geographic Coverage: Americas (including the US, Canada, Mexico, Brazil, Argentina), EMEA (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Companies Analyzed: Ferring B.V., Thermo Fisher Scientific Inc., Abbott Diagnostics, Bayer AG, Cook Group Incorporated, CooperSurgical Inc., F. Hoffmann-La Roche Ltd., FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation), Genea Pty Limited, GlaxoSmithKline PLC, Halotech DNA S.L., Merck & Co., Inc., Qiagen N.V., Theramex (Kanga Health Ltd.).

Key Takeaways for Decision-Makers

  • Digital health platforms and precision medicine are transforming patient pathways, enabling earlier detection and tailored interventions that can improve treatment outcomes and operational efficiency.
  • Strategic collaborations between biotechnology, pharmaceutical, and device manufacturers are accelerating innovation across both diagnostic and therapeutic solutions, driving end-to-end value for clinics and patients.
  • Investments in genetic diagnostics and integrated care models are gaining traction in regions with public-private partnerships, supporting improved patient engagement and enhanced reimbursement opportunities.
  • Regional nuances—such as healthcare infrastructure maturity, regulatory frameworks, and cultural factors—shape market access strategies and competitive approaches.
  • Healthcare supply chain resilience and operational flexibility are increasingly critical as leaders navigate policy shifts, such as those impacting medical device imports or reimbursement schemes.
  • Continuous R&D and alignment with evolving regulatory standards are essential for sustaining growth and meeting rising patient expectations.

Tariff Impact: Navigating Cost Structures and Supply Chains

Recent US tariff policies targeting imported medical devices and components have disrupted supply chains and elevated cost bases for fertility clinics and laboratories. Many organizations are reassessing procurement and vendor relationships, pursuing local manufacturing partnerships, and diversifying sources to maintain service continuity and protect margins. These tariff-driven adjustments are reshaping industry alliances, prompting a renewed focus on operational agility and supply chain risk management.

Methodology & Data Sources

This analysis combines exhaustive secondary research from peer-reviewed literature, regulatory filings, and proprietary databases with primary interviews held with healthcare professionals, laboratory directors, and supply executives. Analytical procedures include trend validation, scenario modeling, and sensitivity testing to ensure consistency and actionable findings for senior stakeholders.

Why This Report Matters

  • Enables evidence-based strategic planning for product development, investment, and go-to-market initiatives in the female infertility diagnosis & treatment market.
  • Equips decision-makers to mitigate risk from tariff policies, supply chain disruptions, and evolving regulatory scenarios through actionable market intelligence.
  • Identifies partnership, technology, and regional opportunities that drive operational resilience and sustainable growth.

Conclusion

Senior leaders in the female infertility sector must adapt to a complex, rapidly evolving marketplace. This report provides critical intelligence for navigating disruption, seizing emerging opportunities, and advancing effective patient care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence algorithms in personalized infertility treatment planning
5.2. Growing adoption of telehealth platforms for virtual fertility consultations and remote monitoring
5.3. Expansion of at home hormone monitoring solutions for early detection of ovulatory disorders
5.4. Advances in non invasive endometrial receptivity assays improving embryo transfer success rates
5.5. Increased use of microfluidic sperm sorting technologies to improve fertilization success in ivf cycles
5.6. Integration of gut microbiome profiling in fertility assessments to personalize treatment decisions
5.7. Regulatory shifts favoring expansion of over the counter fertility diagnostic kits and services
5.8. Emergence of personalized ovarian tissue cryopreservation protocols enhancing fertility preservation outcomes
5.9. Growing emphasis on patient centered digital support tools to reduce emotional stress during infertility treatment
5.10. Patient-centered digital support platforms provide emotional care tools and community engagement during infertility treatments
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Female Infertility Diagnosis & Treatment Market, by Treatment Method
8.1. Introduction
8.2. Assisted Reproductive Technology
8.2.1. Gamete Intrafallopian Transfer
8.2.2. In Vitro Fertilization
8.2.3. Intracytoplasmic Sperm Injection
8.2.4. Intrauterine Insemination
8.3. Cryopreservation
8.3.1. Embryo Cryopreservation
8.3.2. Oocyte Cryopreservation
8.3.3. Sperm Cryopreservation
8.4. Fertility Medications
8.4.1. Clomiphene Citrate
8.4.2. Gonadotropins
8.4.3. Letrozole
8.5. Surgical Intervention
8.5.1. Hysteroscopic Surgery
8.5.2. Laparoscopic Surgery
8.5.3. Myomectomy
8.5.4. Tubal Surgery
9. Female Infertility Diagnosis & Treatment Market, by Diagnosis Technique
9.1. Introduction
9.2. Blood Diagnostics
9.2.1. Anti Mullerian Hormone Test
9.2.2. Follicle Stimulating Hormone Test
9.2.3. Luteinizing Hormone Test
9.2.4. Prolactin Test
9.3. Genetic Testing
9.4. Hysterosalpingography
9.5. Laparoscopy
9.6. Ultrasound Imaging
10. Female Infertility Diagnosis & Treatment Market, by Type of Infertility
10.1. Introduction
10.2. Primary Infertility
10.3. Secondary Infertility
11. Female Infertility Diagnosis & Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Clinic Services
11.2.1. General Gynecology Clinics
11.2.2. Specialized Fertility Clinics
11.3. Home Care Testing
11.4. Hospital Services
11.5. Independent Laboratories
12. Americas Female Infertility Diagnosis & Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Female Infertility Diagnosis & Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Female Infertility Diagnosis & Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Ferring B.V.
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Abbott Diagnostics
15.3.4. Bayer AG
15.3.5. Cook Group Incorporated
15.3.6. CooperSurgical Inc.
15.3.7. F. Hoffmann-La Roche Ltd.
15.3.8. FUJIFILM Irvine Scientific, Inc. by FUJIFILM Holdings Corporation
15.3.9. Genea Pty Limited
15.3.10. GlaxoSmithKline PLC
15.3.11. Halotech DNA S.L.
15.3.12. Merck & Co., Inc.
15.3.13. Qiagen N.V.
15.3.14. Theramex by Kanga Health Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2024 VS 2030 (%)
FIGURE 6. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET: RESEARCHAI
FIGURE 24. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OOCYTE CRYOPRESERVATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OOCYTE CRYOPRESERVATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SPERM CRYOPRESERVATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SPERM CRYOPRESERVATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLOMIPHENE CITRATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLOMIPHENE CITRATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GONADOTROPINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GONADOTROPINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LETROZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LETROZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSCOPIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSCOPIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MYOMECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TUBAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TUBAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ANTI MULLERIAN HORMONE TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ANTI MULLERIAN HORMONE TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FOLLICLE STIMULATING HORMONE TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FOLLICLE STIMULATING HORMONE TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LUTEINIZING HORMONE TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LUTEINIZING HORMONE TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PROLACTIN TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PROLACTIN TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSALPINGOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSALPINGOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRIMARY INFERTILITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRIMARY INFERTILITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SECONDARY INFERTILITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SECONDARY INFERTILITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENERAL GYNECOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENERAL GYNECOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 143. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2024 (USD MILLION)
TABLE 144. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2025-2030 (USD MILLION)
TABLE 145. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 146. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 147. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2024 (USD MILLION)
TABLE 148. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2025-2030 (USD MILLION)
TABLE 149. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 150. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 151. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 152. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 153. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 154. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 155. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 156. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 157. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2024 (USD MILLION)
TABLE 158. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2025-2030 (USD MILLION)
TABLE 159. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2024 (USD MILLION)
TABLE 162. CANADA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2025-2030 (USD MILLION)
TABLE 163. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2024 (USD MILLION)
TABLE 164. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2025-2030 (USD MILLION)
TABLE 165. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 166. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 167. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2024 (USD MILLION)
TABLE 168. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2025-2030 (USD MILLION)
TABLE 169. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 172. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 173. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2024 (USD MILLION)
TABLE 178. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2025-2030 (USD MILLION)
TABLE 179. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2024 (USD MILLION)
TABLE 182. MEXICO FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DI

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Female Infertility Diagnosis & Treatment market report include:
  • Ferring B.V.
  • Thermo Fisher Scientific Inc.
  • Abbott Diagnostics
  • Bayer AG
  • Cook Group Incorporated
  • CooperSurgical Inc.
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Irvine Scientific, Inc. by FUJIFILM Holdings Corporation
  • Genea Pty Limited
  • GlaxoSmithKline PLC
  • Halotech DNA S.L.
  • Merck & Co., Inc.
  • Qiagen N.V.
  • Theramex by Kanga Health Ltd.

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.29 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.85 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Female Infertility Diagnosis - Global Strategic Business Report - Product Image

Female Infertility Diagnosis - Global Strategic Business Report

  • Report
  • 176 Pages
  • Global
From
Female Infertility Market Report 2025 - Product Image

Female Infertility Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Female Infertility - Pipeline Insight, 2025 - Product Image

Female Infertility - Pipeline Insight, 2025

  • Drug Pipelines
  • 75 Pages
  • Global
From
Infertility Treatment Market - Global Forecast 2025-2030 - Product Image

Infertility Treatment Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Management of Infertility. A Practical Approach - Product Image

Management of Infertility. A Practical Approach

  • Book
Copyright © 2002-2025 Research and Markets. All Rights Reserved.